postmenopausal osteoporosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female aged 55-70 years, natural menopause; 2. The T value of lumbar bone mineral density measured by dual-energy X-ray absorptiometry (DXA) was <= -2.5; 3. Have symptoms of low back pain; 3. The patient is informed and willing to sign the informed consent form, can better communicate in language or written form, and has good compliance.
Exclusion criteria
Exclusion criteria: 1. In the past 6 months, he has received drugs that can interfere with bone metabolism, such as glucocorticoids, calcitonin, estrogen, bisphosphate, etc; 2. Patients with thyroid disease, osteomalacia, rheumatoid arthritis, tumor, Cushing's disease, diabetes, liver and kidney dysfunction, blood system diseases and other bone metabolic diseases; 3. Removal of uterus or ovary; 4. Wearing implantable cardiac pacemaker; 5. Patients with mental disorders who cannot cooperate with the treatment research program; 6. Other researchers believe that it is not suitable for patients to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bone mineral density;bone turnover marker;ALP;ALP;Visual Analogue Scale (VAS) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine; | — |
Countries
China
Contacts
Honghui Hospital, Xi’an Jiaotong University